Conference Sessions

Session I
S1 - COMPARISON OF TWO REAL TIME PCR METHODS AND A CONVENTIONAL PCR TEST FOR THE QUANITIFICATION OF CYTOMEGALOVIRUS (CMV) IN PLASMA
S2 - PERFORMANCE EVALUATION OF THE ARTUS CYTOMEGALOVIRUS (CMV) PCR ASSAY FOR ANALYTICAL AND CLINICAL SENSITIVITY
S3 - DETERMINATION OF CMV VIRAL LOAD BY ARTUS (QIAGEN) CMV REAL-TIME PCR ANALYTE-SPECIFIC REAGENT USING LIGHTCYCLER
S4 - DETECTION OF CYTOMEGALOVIRUS IN CLINICAL SAMPLES USING THREE DIFFERENT REAL-TIME PCR CHEMISTRIES
S5 - PERFORMANCE CHARACTERISTICS OF A MULTICODE-RTx® PCR ASSAY FOR THE QUANTITATIVE DETECTION OF CYTOMEGALOVIRUS DNA IN PLASMA AND URINE
S6 - COMPARISON OF AN IN-HOUSE DEVELOPED AND TWO COMMERCIAL ASSAYS (LIGHT TM AND CMV BRITETM )FOR QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS PP65-ANTIGENEMIA
S7 - ASSESSMENT OF PERFORMANCE OF QUALITY CONTROL SAMPLES USED IN REAL TIME QUANTITATIVE PCR FOR MONITORING VIRAL LOAD OF CMV, EBV, BKV IN ORGAN TRANSPLANT RECIPIENTS
S8 - POLYMORPHISMS OF GENES IN HCMV UL/B' REGION OF CLINICAL STRAINS
S9 - THREE CMV pp65 ANTIGENEMIA ASSAYS VERSUS QUANTITATIVE REAL TIME PCR AN UNJUST COMPARISON
S10 - HIGH CMV IgM ANTIBODY LEVELS CORRELATE WITH LOW CMV IgG AVIDITY AND MAY BE A USEFUL INDICATOR OF PRIMARY CMV INFECTION
S11 - INITIAL EVALUATION OF BECKMAN SPRI-TE SYSTEM FOR EXTRACTION OF DNA FROM WHOLE BLOOD AND QUANTITATIVE CMV DETECTION BY POLYMERASE CHAIN REACTION
S12 - DIFERENTIAL DIAGNOSTIC HEPATOTROPIC AND NO HEPATOTROPIC VIRUSES IN MARACAIBO-VENEZUELA- AÑO 2007
S13 - PLEXUS EPSTEIN-BARR VIRUS (EBV) IGG AND IGM MULTI-ANALYTE DIAGNOSTICS: MULTIPLEX BEAD-BASED ASSAYS FOR EBV SERUM ANTIBODY DETECTION
S14 - EVALUATION OF THE PLEXUS EPSTEIN-BARR VIRUS MULTI-ANALYTE PANELS FOR DETECTION OF IGG AND IGM CLASS ANTIBODIES TO EBV
S15 - DETECTION OF HETEROPHILE ANTIBODIES USING A MULTIPLEX FLOW IMMUNOASSAY
S16 - MULTICENTER QUALITY CONTROL STUDY OF QUANTIFICATION OF EPSTEIN-BARR VIRUS DNA LOAD IN WHOLE BLOOD SPECIMENS BY THE FRENCH ANRS WORKING GROUP AC11
S17 - VALIDATION OF ORAGENE DNA SELF- COLLECTION KIT FOR REAL-TIME EBV DNA VIRAL LOAD
S18 - SUSCEPTIBILITY OF EPSTEIN BARR VIRUS (EBV) STRAINS TO CANDIDATE ANTIVIRAL DRUGS
S19 - SEROEPIDEMIOLOGY OF ETIOLOGIC AGENTS OF THE ToRCH SYNDROME IN AMERINDIAN WOMEN IN FERTILE AGE FROM ZULIA STATE, VENEZUELA PRELIMINARY RESULTS
S20 - HERPES INFECTION OR ITS DIFFERENTIAL DIAGNOSIS PHYTOPHOTODERMATITIS
S21 - EVALUATION OF H&V-MIXTM FRESH CELL FOR THE RAPID TURN-AROUND-TIME IN THE DETECTION OF VZV, HSV, AND CMV
S22 - COMPARISION OF DIRECT FLOURESCENT ANTIBODY (DFA) STAINS FOR THE DETECTION OF HERPES SIMPLEX VIRUS 1 & 2 (HSV 1/2) AND VARICELLA-ZOSTER VIRUS (VZV) IN MRC5 AND H&V-MIXTM SHELL VIAL CULTURES
S23 - HERPES ZOSTER WITH MENINGITIS CAUSED BY TWO DIFFERENT VARICELLA VACCINE-ASSOCIATED VARICELLA-ZOSTER VIRUS STRAINS
S24 - DETECTION OF VZV IN HSV-NEGATIVE CSF SAMPLES AND HSV IN VZV-NEGATIVE CSF SAMPLES BY SimplexaTM VIRAL ENCEPHALITIS ASSAY
S25 - COMPARISON OF THE MAGNA PURE EXTRACTOR TO A SWAB LYSIS METHOD FOR THE DETECTION OF HSV AND VZV IN CLINICAL SPECIMENS BY REAL-TIME PCR
S26 - DEVELOPMENT OF A NEW DIAGNOSTIC TOOL FOR THE QUANTITATIVE DETECTION OF HSV-1, HSV-2, AND VZV DNA
S27 - A SENSITIVE AND SPECIFIC LATERAL-FLOW BASED RAPID POINT-OF-CARE
S28 - MORE RAPID ISOLATION OF HERPES SIMPLEX VIRUS STRAINS, RESISTANT TO ACYCLOVIR WITH DIFFERENT tk GENE MUTATIONS IN A CONTINUOUS LINE OF HUMAN RHABDOMYOSARCOMA CELLS THAN IN LARYNGEAL CARCINOMA OR BOVINE KIDNEY CELLS
S29 - COMPARISON OF THE LIAISON® HSV-1 AND HSV-2 TYPE SPECIFIC AUTOMATED IMMUNOASSAYS TO HERPESELECT® 1 AND 2 IMMUNOBLOT
S30 - EVALUATION OF ARGENES RESEARCH USE ONLY, REAL-TIME PCR REAGENTS FOR HSV1 AND HSV2 R-GENETM
S31 - EVALUATION OF AN MGB REAL TIME PCR REAGENT FROM NANOGEN FOR HERPES SIMPLEX VIRUS DETECTION AND TYPING
S32 - REAL-TIME PCR DETECTION OF HERPES SIMPLEX VIRUS IN CSF USING THE SPARTAN DXTM
S33 - CLINICAL RESEARCH STUDY OF ARCHIVED CSF SAMPLES FROM PATIENTS SUSPECTED HERPES SIMPLEX ENCEPHALITIS USING INTELLIGENT MEDICAL DEVICES, INC. HERPES SIMPLEX VIRUS REAL-TIME PCR REAGENTS
S34 - EVALUATION OF FOUR COMMERCIAL REAL-TIME PCR ANALYTE-SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID AND BLOOD
S35 - PERFORMANCE OF THREE DIFFERENT HSV ID/TYPING ASSAYS FOR DETECTION AND TYPING OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID
S36 - PERFORMANCE OF THREE DIFFERENT HSV ID/TYPING ASSAYS FOR DETECTION AND TYPING OF HERPES SIMPLEX VIRUS IN CEREBROSPINAL FLUID
S37 - THE ROLE OF HUMAN HERPES VIRUS 6 IN ENCEPHALITIS PATIENTS
S38 - COMPARISON OF THE MGB ALERT® BK VIRUS 2.0 DETECTION REAGENT ASR (NANOGEN) WITH A -HOME-BREW- TAQMAN ASSAY FOR DETECTION OF BK VIRUS
S39 - EVALUATION OF NANOGEN BK VIRUS ASR FOR BLOOD AND URINE SPECIMENS PERFORMED USING SMARTCYCLER
S40 - A NEW BK PCR ASSAY WITH IMPROVED DETECTION OF ALL RECENTLY DESCRIBED VARIANT GENOTYPES
S41 - TRANSPLANT-RELATED VIRAL INFECTION AND CO-INFECTION RATES
S43 - GENOTYPING OF MUMPS VIRUS IN CANADA
S44 - MUMPS IN CANADA: THE ALBERTA EXPERIENCE 2007 TO NOW
S45 - EVALUATION OF A MULTIPLEX IMMUNOASSAY FOR THE SEROLOGIC DETECTION OF IGG CLASS ANTIBODY TO RUBEOLA, MUMPS, RUBELLA AND VARICELLA ZOSTER VIRUS
S46 - DETECTION OF RUBELLA VIRUS RNA IN DRIED BLOOD SPOT AND SERUM SPECIMENS
S47 - GENOTYPING OF MEASLES VIRUS IN CANADA: 2002 - 2008
S48 - SYNTHESIS OF A CHIMERIC IGM IMMUNOGLOBULIN SPECIFIC TO THE MEASLES NUCLEOPROTEIN FOR USE AS A POSITIVE CONTROL IN MEASLES DIAGNOSTIC TESTS AND PROFICIENCY PANELS
S49 - USE OF THE MEMBRANE GLYCOPROTEINS OF NIPAH VIRUS TO DEVELOP NEW DIAGNOSTIC TESTS
S50 - DETECTION OF ADENOVIRUS DNA FROM CLINICAL SPECIMENS USING COMMERCIAL REAL-TIME PCR REAGENTS
S51 - ADENOVIRUS 14 DETECTION AND SURVEILLANCE IN AN OREGON HEALTH SYSTEM FROM 2005-2007
S52 - REAL-TIME PCR WITH AN INTERNAL CONTROL DETECTING ALL KNOWN HUMAN ADENOVIRUS SEROTYPES
S53 - MOLECULAR AND PHENOTYPIC CHARACTERIZATION OF EMERGING ADENOVIRUS 14 STRAIN ASSOCIATED WITH RECENT OUTBREAKS OF RESPIRATORY DISEASE IN THE UNITED STATES
S54 - A COMMERCIAL REAL TIME PCR FOR ADENOVIRUSES
S55 - REAL-TIME PCR FOR RAPID DETERMINATION OF ANTIVIRAL DRUG SUSCEPTIBILITY OF ADENOVIRUS
S56 - ADENOVIRUSES DETECTED IN AUTOPSIES, NEW YORK, 2007
S57 - RAPID, SENSITIVE, SPECIFIC DETECTION OF ENTEROVIRUSES AND RHINOVIRUSES USING A REAL-TIME PCR FOR ENTEROVIRUSES THAT DETECTS ALL RHINOVIRUSES BY GEL ELECTROPHORESIS
S58 - RT-PCR ASSAYS USED TO IDENTIFY NEW HUMAN RHINOVIRUSES
S59 - DETECTION OF HUMAN RHINOVIRUSES BY REAL TIME PCR
S60 - SYBR GREEN I-BASED REAL-TIME PCR REVEALED A HIGH INCIDENCE OF HUMAN BOCAVIRUS (HBOV) INFECTION IN THE PEDIATRIC POPULATION FROM PORTO ALEGRE, BRAZIL
S61 - DEVELOPMENT, EVALUATION AND COMPARISON OF REAL-TIME PCR ASSAYS FOR DETECTION OF HUMAN BOCAVIRUS IN RESPIRATORY SAMPLES
S62 - SEVERE DISEASE ASSOCIATED WITH ACUTE HUMAN BOCAVIRUS INFECTION
S442 - EVALUATION OF ASSAYS FOR THE RAPID DIAGNOSIS OF MUMPS VIRUS RNA IN CLINICAL SPECIMENS

Session II
M1 - EVALUATION OF THE TRUtm RSV TEST FOR RAPID DETECTION OF RESPIRATORY SYNCYTIAL VIRUS IN PEDIATRIC PATIENTS
M2 - DEVELOPMENT OF A MULTIPLEX MNAZYME ASSAY FOR RSV VIRAL QUANTIFICATION, MONITORED BY AN INTERNAL EXTRACTION CONTROL AND AN EXTERNAL QUANTIFICATION CONTROL
M3 - COMPARISON OF A RAPID ANTIGEN TEST AND REAL-TIME POLYMERASE CHAIN REACTION FOR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS FROM CHILDREN HOSPITALIZED WITH LOWER RESPIRATORY TRACK INFECTIONS
M4 - COMPARISON OF THE AMOUNT OF RESPIRATORY SYNCYTIAL VIRUS COLLECTED USING NASOPHARYNGEAL WASH AND NASOPHARYNGEAL FLOCKED SWAB TECHNIQUES FROM CHILDREN HOSPITALIZED WITH LOWER RESPIRATORY TRACT INFECTIONS
M5 - COMPARISON OF DIAGNOSTIC HYBRIDS D3 DUET (RSV AND INFLUENZA), D3 DOUBLE DUET AND D3 ULTRA DFA SCREENING REAGENTS FOR THE DETECTION OF 8 RESPIRATORY VIRUSES IN DIRECT SPECIMENS
M6 - EVALUATION OF PROFLU+ FOR REAL-TIME AMPLIFICATION AND DETECTION OF INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUSES
M7 - COMPARISON OF NASOPHARYNGEAL (NP) SWABS COLLECTED WITH PERNASAL FLOCKED SWABS VERSUS TO NP SWABS COLLECTED WITH TRADITIONAL TWISTED WIRE FIBER MINITIP FOR THE DETECTION OF RESPIRATORY VIRUSES USING SIMULFLUOR DFA
M8 - CLINICAL PERFORMANCE OF FOAM VS. FLOCKED SWABS COLLECTED FROM THE ANTERIOR NARES IN A RAPID ANTIGEN TEST FOR INFLUENZ A & B
M9 - A MICROARRAY-BASED APPROACH TO INFLUENZA A DIAGNOSIS AND SURVEILLANCE
M10 - GREATER THAN 10% OF INFLUENZA A (H1N1) ISOLATES AT CENTRAL PUBLIC HEALTH LABORATORY (CPHL), TORONTO, ONTARIO, CANADA ARE POSITIVE FOR THE NEURAMINIDASE H274Y MUTATION
M11 - EVALUATION OF SIMPLEXATM FLU-RSV ASSAY PERFORMANCE WITH ROCHE MAGNA PURE LC, BIOMERIEUX NUCLISENS® EASYMAGTM, AND QIAGEN QIAAMP® VIRAL RNA EXTRACTIONS
M12 - UTILITY OF MULTIPLEX REVERSE TRANSCRIPTION/REAL TIME PCR FOR DETECTION OF RSV, INFLUENZA A, AND INFLUENZA B IN NASOPHARYNGEAL ASPIRATES
M13 - ERAGEN INFLUENZA REAL-TIME PCR ASSAY EVALUATION ON THE LIGHT CYCLER BY COMPARISON WITH EIA AND PMK SHELL VIAL
M14 - EVALUATION OF THE NucliSENS EasyQ® INFLUENZA A/B ASSAY FOR THE DETECTION OF INFLUENZA A AND B VIRUSES
M15 - ADVANCES IN THE AUTOMATED DETECTION AND SUBTYPING OF INFLUENZA VIRUSES THAT INFECT HUMANS
M16 - PRE-CLINICAL EXPERIENCE WITH THE FluIDTM RAPID INFLUENZA TEST
M17 - RAPID DETECTION OF INFLUENZA VIRUSES: PERFORMANCE CHARACTERISTICS OF DIRECTIGEN EZ FLU A + B AND BINAXNOW® INFLUENZA A & B TESTS
M18 - CLINICAL EVALUATION OF THE 3M RAPID DETECTION FLU A+B TEST
M19 - IMPROVED SENSITIVITY FOR CULTURING AND IDENTIFYING INFULENZA A SUBTYPES USING MDCK CELLS WITH ENHANCED EXPRESSION OF ALPHA 2, 6 LINKED SIALIC ACID MIXED WITH A-549 CELLS
M20 - GENETICALLY ENGINEERED CELL LINES EXPRESSING INFLUENZA VIRUS-INDUCIBLE REPORTER GENES AS TOOLS FOR DETECTING AND QUANTIFYING INFLUENZA A OR B VIRUS
M21 - SURVEILLANCE OF ANTIVIRAL RESISTANT INFLUENZA FROM 2006-2008 BY A NETWORK OF U.S. STATE PUBLIC HEALTH LABORATORIES
M22 - IDENTIFICATION OF MUTATIONS IN THE INFLUENZA A GENOME ASSOCIATED WITH ADAMANTANE AND NEURAMINIDASE INHIBITOR RESISTANCE DIRECTLY FROM CLINICAL SPECIMENS
M23 - DETECTION OF RNA AND NUCLEOPROTEIN ANTIGEN OF INFLUENZA A VIRUS IN STOOL OF CHILDREN
M24 - DIRECT DETECTION OF INFLUENZA VIRUS TYPES A AND B IN CLINICAL SPECIMENS DURING THE 2007/2008 RESPIRATORY SEASON: ANTIGEN vs. PCR
M25 - DIRECT DETECTION OF HUMAN METAPNEUMOVIRUS (hMPV) RNA IN RESPIRATORY SPECIMENS FROM PATIENTS PRESENTING WITH INFLUENZA-LIKE ILLNESS IN HAWAII
M26 - COMPARISON OF R-MIX TOOTM FRESH CELLS WITH CONVENTIONAL CELLS LINES FOR THE RAPID TURN-AROUND-TIME IN THE DETECTION OF RESPIRATORY PATHOGENS USING THE DIAGNOSTIC HYBRID'S D³ ULTRATM RESPIRATORY SCREENING AND IDENTIFICATION REAGENTS
M27 - COMPARISON OF COPAN FLOCKED SWABS TO ROUTINE DACRON SWABS FOR THE COLLECTION OF NASOPHARYNGEAL SWABS FOR THE DIAGNOSIS OF RESPIRATORY VIRUSES
M28 - COMPARISON OF A MID-TURBINATE FLOCKED SWAB TO A NASOPHARYNGEAL FLOCKED SWAB FOR RESPIRATORY VIRUS DETECTION IN CHILDREN
M29 - RESPIRATORY VIRAL RECOVERY FROM PEDIATRIC ASOPHARYNEGEAL SPECIMENS USING FLOCKED SWABS
M30 - EVALUATION OF THE COPAN MID-TURBINATE FLOCKED SWAB FOR THE COLLECTION OF RESPIRATORY SPECIMENS FOR CELL CULTURE
M31 - A COMPARISON OF NASOPHARYNGEAL AND MIDTURBINATE REGION SAMPLING FOR THE DETECTION OF RESPIRATORY PATHOGENS
M32 - FLOCKED SWABS CAN BE USED WITH DRY SPECIMEN TRANSPORT IN NUCLEIC ACID AMPLIFICATION ASSAYS FOR THE SURVEILLANCE OF PANDEMIC INFLUENZA
M33 - SELF-COLLECTED NASAL SWABS FOR DIAGNOSIS OF RESPIRATORY VIRUSES
M34 - RECOVERY OF RESPIRATORY VIRUSES: SAMPLES COLLECTED BY FLOCKED SWABS COMPARED TO NASAL ASPIRATES
M35 - PERFORMANCE OF RAPID EIA, DFA, RMIX, AND CONVENTIONAL CULTURE FOR DETECTION OF RESPIRATORY VIRUSES IN PEDIATRIC VS ADULT POPULATIONS
M36 - DETECTION OF RESPIRATORY VIRUSES IN NASOPHARYNGEAL ASPIRATES: COMPARISON OF DIRECT FLUORESCENT ANTIBODY TESTING AND XTAG RESPIRATORY VIRAL PANEL
M37 - ENHANCED DETECTION OF RESPIRATORY VIRUSES IN SYMPTOMATIC ADULTS USING THE LUMINEX xTAGTM RVP ASSAY
M38 - ENHANCED ETIOLOGICAL DIAGNOSIS OF RESPIRATORY VIRUS OUTBREAKS USING NUCLEIC ACID AMPLIFICATION TESTING AGAINST AN EXPANDED RANGE OF TARGETS
M39 - COMPARISON OF REAL-TIME NUCLEIC ACID AMPLIFICATION TESTING FOR RESPIRATORY VIRUSES WITH THE LUMINEX RVP ASSAY
M40 - EVALUATION OF THE QIAGEN RESPLEX II ASSAY AND CORRELATION WITH THE CEPHEID SMART CYCLER ASR (INFLUENZA A AND B, RSV, AND ENTEROVIRUS) AND EIA ASSAYS
M41 - AUTOMATED EXTRACTION PLATFORMS AS FRONT END FOR RESPLEX II, SIMULTANEOUS DETECTION AND IDENTIFICATION OF A PANEL OF RESPIRATORY RNA VIRUSES IN RESPIRATORY SAMPLES
M42 - PRACTICAL OBSERVATIONS FROM THE IMPLEMENTATION OF HIGHLY MULTIPLEX MOLECULAR TESTING AS A ROUTINE PART OF RESPIRATORY DIAGNOSIS
M43 - THE SEEPLEX RV DETECTION KIT IDENTIFIES PATHOGENS IN THE MAJORITY OF RESPIRATORY OUTBREAKS FROM THE GREATER TORONTO AREA, ONTARIO, CANADA
M45 - HIGH THROUGHPUT MOLECULAR DIAGNOSTICS FOR RESPIRATORY VIRUSES
M46 - ANALYSIS OF 250 PEDIATRIC NPA SAMPLES FOR 22 RESPIRATORY PATHOGENS USING AN AUTOMATED, NESTED MULTIPLEX PCR PLATFORM
M47 - DETECTION RATES OF HUMAN CORONAVIRUS TYPES OC43, 229E, HKU1 AND NL63 IN CHILDREN HOSPITALIZED WITH ACUTE RESPIRATORY INFECTIONS AND WELL CHILDREN
M48 - DETECTION OF RESPIRATORY VIRUS OUTBREAKS IN CHILDREN: A COMPARISON OF MOLECULAR LABORATORY-BASED SURVEILLANCE VERSUS TELEPHONE-BASED SYNDROMIC SURVEILLANCE
M49 - ETIOLOGY OF RESPIRATORY VIRAL INFECTIONS USING RAPID VIRUS ISOLATION METHODS: EXPERIENCE AT A TERTIARY CARE CENTER IN RIYADH, SAUDI ARABIA
M50 - COMPARISON OF METHODS IN THE DETECTION OF RESPIRATORY VIRUSES
M51 - AUTOMATED MOLECULAR DIAGNOSTIC OF RESPIRATORY VIRUSES IN CHILDREN
M52 - SINGLE RESPIRATORY COLLECTION SYSTEM, STARPLEX S-160 NASO, FOR MULTIPLE INVESTIGATIONS
M53 - EVALUATION OF R-MIX TOO VIALS FOR CULTURE OF RESPIRATORY VIRUSES
M54 - COMPARISON OF EIA, DFA, AND CULTURE FOR DETECTION OF HUMAN METAPNEUMOVIRUS
M55 - COMPARISON OF PREVALENCE AND CLINICAL FEATURES OF PEDIATRIC RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS
M56 - EVALUATION OF THE PRODESSE PRO HMPV+ ASSAY -A REAL TIME RT-PCR TEST FOR DETECTION OF HUMAN METAPNEUMOVIRUS FROM CLINICAL TRIALS IN A PEDIATRIC PATIENT POPULATION
M57 - DETECTION OF HUMAN METAPNEUMOVIRUS IN NASOPHARYNGEAL ASPIRATES: PREVALENCE AND EFFICACY OF DETECTION BY DIRECT FLUORESCENT ANTIBODY
M58 - OBSERVATIONS ON METAPNEUMOVIRUS TESTING
M59 - EVALUATION OF A REAL-TIME ASSAY FOR HUMAN METAPNEUMOVIRUS DETECTIONBackground: Human metapneumovirus (hMPV), a newly described member of the Paramyxoviridae family, has been shown to be a cause of acute respiratory tract infections in young children, the
M60 - EVALUATION OF NUCLISENSE ANALYTE SPECIFIC REAGENTS (ASR) FOR THE DETECTION OF HUMAN METAPNEUMOVIRUS IN CLINICAL SPECIMENS
M61 - EVALUATION OF IMAGEN HMPV - A NEW DIRECT FLUORESCENT ANTIBODY TEST
M62 - A COMPARISON OF NEW IMAGEN hMPV IMMUNOFLUORESCENT ANTIBODY ASSAY VS PCR
M63 - COMPARISON OF TWO NEW DFA ASSAYS TO RT-PCR FOR THE DETECTION OF HUMAN METAPNEUMOVIRUS IN RESPIRATORY SPECIMENS

Session III
TM1 - COMPARISON OF THREE COMMERCIAL ENZYME IMMUNOASSAYS AND SUITABILITY OF A RECOMBINANT LINE ASSAY FOR DIFFERENTIATION OF THE INFECTION STATE IN ROUTINE PARVOVIRUS B19 SEROLOGY
TM2 - DRIED BLOOD SPOT (DBS) AS A VALIDATED COLLECTION AND SAMPLE TYPE FOR THE DETECTION OF PARVOVIRUS B19-SPECIFIC IGG AND IGM IN COMMERCIAL EIAs
TM3 - EVALUATION OF DRIED PLASMA SPOTS FOR SEQUENCE ANALYSIS OF BLOOD-BORNE VIRUSES
TM4 - LONG-TERM STABILITY OF VIRAL MARKERS IN PLASMA
TM5 - IMPROVED SIGNAL-TO-CUTOFF RATIO THRESHOLD FOR HBsAg CONFIRMATORY TESTING OF CLINICAL SERUM SPECIMENS REACTIVE BY THE VITROS HBsAg ASSAY
TM6 - PREVALENCE OF HEPATITIS A VIRUS (HAV) AND HEPATITIS B VIRUS (HBV) IN PATIENTS FROM MARACAIBO, VENEZUELA
TM7 - Abstract Withdrawn
TM8 - HBV DNA QUANTITATED BY COBAS TAQMAN REAL-TIME PCR: THE MANUAL HIGH PURE COMPARED TO COBAS AMPLIPREP EXTRACTION TECHNIQUES
TM9 - MANUAL QIAGEN VS ROCHE AMPLIPREP -TNAI- EXTRACTION OF HBV DNA FOR ASSAY WITH THE ROCHE HBV TAQMAN ASR
TM10 - COMPARISON OF MULTICODE®-RTx HCV ASSAY WITH COBAS® TAQMAN HCV ASR
TM11 - PERFORMANCE EVALUATION OF THE COBAS® AMPLIPREP/ COBAS® TaqMan® HCV TEST
TM12 - ARUPs EXPERIENCE WITH THE ROCHE HCV CAP/CTM DIAMOND STUDY
TM13 - QUANTIFYING HEPATITIS C VIRUS (HCV) RNA: THREE PCR INSTRUMENT PLATFORMS COUPLED WITH MANUAL OR ROBOTIC INSTRUMENT SAMPLE EXTRACTION
TM14 - Abstract Withdrawn
TM15 - EVALUATION OF THE COBAS AmpliPrep/COBAS TaqMan SYSTEM FOR HCV QUANTIFICATION
TM16 - EVALUATION OF THE AUTOMATED COBAS® AMPLIPREP/COBAS® TAQMAN® ASSAY FOR QUANTITATION OF HCV
TM17 - THE EFFECT OF SPECIMEN PROCESSING AND STORAGE CONDITIONS ON THE STABILITY OF HEPATITIS C VIRUS RNA IN SERUM AND PLASMA
TM18 - COMPARISON OF MULTICODE®-RTX HCV (ERAGEN BIOSCIENCES) AND VERSANT® HCV RNA 3.0 bDNA (SIEMENS) HEPATITIS C VIRAL LOAD ASSAYS
TM19 - TH-1 (IL-2) AND TH-2 (IL-10) IMMUNE RESPONSES OF AMERINDIANS WITH CHRONIC INFECTION BY HEPATITIS B IN THE JAPREIRA COMMUNITY, ZULIA, VENEZUELA
TM20 - CONTROL OF HEPATITIS C VIRUS INFECTION IN PATIENTS UNDERGOING DIALYSIS TREATMENT IN MARACAIBO, VENEZUELA
TM21 - LOW PREVALENCE OF HEPATITIS C VIRUS IN A PRISONER POPULATION FROM MARACAIBO, VENEZUELA
TM22 - SVR IS INDEPENDENT OF BASELINE HCV RNA LOAD IN PATIENTS TREATED WITH HIGH DOSE INTERFERON INDUCTION THERAPY
TM24 - PERFORMANCE OF A MULTICODE®-RTX HCV ASSAY AMONG CLINICAL SPECIMENS CONTAINING HCV GENOTYPES 1 TO 6
TM25 - INCLUSION OF A SECOND SCREENING ASSAY TO DETERMINE THE SEROLOGIC CONFIRMATION OF HCV ANTIBODIES AMONG AN HIV POSITIVE POPULATION FROM ARGENTINA
TM26 - ABBOTT REALTIME HIV-1 ASSAY: A VIRAL LOAD ASSAY WITH HIGHLY RELIABLE AND REPRODUCIBLE RESULTS
TM27 - EVALUATION OF THE ABBOTT HIV-1 QUANTITATIVE REAL TIME PCR ASSAY
TM28 - EVALUATION OF EFFECTS OF PLASMA SAMPLE HANDLING AND POTENTIAL INTERFERING DISEASE STATES ON VERSANT® HIV-1 RNA 1.0 ASSAY (KPCR) PERFORMANCE
TM29 - VERIFICATION OF THE HIV REAL-TIME PCR ASSAY COBAS AMPLIPREP/COBAS TAQMAN 48 HIV-1 TEST COMPARISON WITH THE SIEMENS bDNA VERSANT HIV-1 V 3.0 ASSAY
TM30 - MULTICENTER EVALUATION OF THE VERSANT® HIV-1 RNA 3.0 ASSAY [bDNA] WITH THE VERSANT 440 MOLECULAR SYSTEM
TM31 - COMPARISON OF THE MEASUREMENT OF HIV RNA VIRAL LOAD USING ROCHE COBAS® AMPLIPREP®\COBAS® TAQMAN® ASSAY VS. ROCHE COBAS AMPLICOR ASSAY
TM32 - THE ROCHE AMPLIPREP-TAQ 48 SYSTEM FOR HIV-1 QUANTIFICATION IMPROVES THE PERFORMANCE AND DECREASES TECHNICAL TIME COMPARED TO THE ROCHE COBAS AMPLICOR SYSTEM
TM33 - DILUTION OF SMALL VOLUME SAMPLES FOR PEDIATRIC HIV-1 VIRAL LOAD REAL-TIME PCR TESTING
TM34 - EVALUATION OF THE ROCHE CAP/CTM HIV-1 ASSAY
TM35 - INCIDENCE OF TRANSIENT DETECTABLE HIV-1 VIREMIA ("BLIPS") WHEN MEASURED BY bDNA METHODOLOGY (VERSANT, 3.0, SIEMENS) IS LOWER THAN HISTORICAL INCIDENCE RATES MEASURED BY PCR (AMPLICOR 1.5, ROCHE DIAGNOSTICS)
TM36 - GENOTYPIC ANALYSIS RESULTS OF NEWLY POSITIVE, LOW-LEVEL VIRAL LOADS (HIV RNA <250 COPIES/ML) PERFORMED BY bDNA (VERSANT, 3.0, SIEMENS) HAVE A SIMILAR CLINICAL IMPACT ON ANTIRETROVIRAL THERAPY DECISIONS AS DO HIGHER LEVEL NEWLY POSITIVE VIRAL LOADS (HIV RN
TM37 - A NOVEL SYSTEM TO PRODUCE FULLY INFECTIOUS HIV-1 AND ITS USE IN THE DETERMINATION OF RESISTANCE TO PROTEASE, REVERSE TRANSCRIPTASE, & INTEGRASE INHIBITORS IN A SINGLE ASSAY
TM38 - DEVELOPMENT OF A GENOTYPING ASSAY FOR HIV-1 INTEGRASE
TM39 - SEQUENCE-SPECIFIC VISUAL DETECTION OF AMPLIFIED HIV-1 BY LAMP/ RT-LAMP
TM40 - AMPLICOR HIV-1 DNA PCR TEST VERSION 1.5 USING 100 UL OF WHOLE BLOOD AND 200 UL OF SPECIMEN DILUENT
TM41 - ANALYSIS OF RAPID ORAQUICK HIV-1/2 TEST IN SERA WITH POSITIVE HIV-1/2 EIA BUT UNCONFIRMED HIV-1 WESTERN BLOT RESULTS
TM43 - ANONYMOUS UNLINKED SEROPREVALENCE OF HUMAN MMUNODEFICIENCY VIRUS (HIV) ANTIBODY IN THREE EMERGENCY DEPARTMENTS-USING POOLED SERA TESTING
TM44 - STABILITY OF HIV-1 VIRAL LOAD FROM DRIED PLASMA USING
TM45 - COMPARISON OF SENSITROP II, A SECOND GENERATION MOLECULAR HIV CO-RECEPTOR TROPISM ASSAY, TO TROFILE, A CELL-BASED HIV CO-RECEPTOR TROPISM ASSAY, ON TREATMENT EXPERIENCED HIV PATIENT SPECIMENS
TM46 - DISTRIBUTION OF HPV GENOTYPES AND CORRELATION OF THE PRETECT HPV-PROOFER TEST IN INVASIVE CERVICAL CANCER IN INDIA
TM47 - A MULTI-CENTER STUDY OF THE REPRODUCIBILITY CHARACTERISTICS OF TWO INVESTIGATIONAL USE ONLY HPV TESTS
TM48 - EVALUATION OF INVADER® HPV REAGENTS (ASR) FOR THE DETECTION OF HUMAN PAPILLOMA VIRUS COMPARED TO THE HYBRID CAPTURE® 2 HIGH-RISK HPV DNA TEST
TM49 - EVALUATION OF THE ANALYTICAL PERFORMANCE OF A HUMAN PAPILLOMAVIRUS GENOTYPING ASSAY: THE INFINITI HPV-QUAD ASSAY
TM50 - MALDI-TOF MASS SPECTROMETRY FOR HUMAN PAPILLOMAVIRUS GENOTYPING
TM51 - CHARACTERIZATION OF THE ANALYTICAL PERFORMANCE OF THE INVESTIGATIONAL USE ONLY INVADER HPV 16/18 MOLECULAR ASSAY
TM52 - ANALYTICAL PERFORMANCE CHARACTERISTICS OF THE INVESTIGATIONAL USE ONLY INVADER HPV HR MOLECULAR ASSAY
TM53 - EVALUATION OF INVADER HPV ASR AS AN ALTERNATIVE FOR THINPREP SPECIMENS WHERE QUANTITY IS NOT SUFFICIENT FOR HYBRID CAPTURE 2 TESTING
TM54 - PERFORMANCE OF A LAB-DEVELOPED ASSAY USING INVADER HPV ASR ON 1000 CONSECUTIVE THINPREP SPECIMENS AND COMPARED WITH HYBRID CAPTURE 2 AND CYTOLOGY RESULTS
TM55 - COMPARISON OF THE DIGENE HYBRID CAPTURE 2 ASSAY AND THE THIRD WAVE TECHNOLOGIES INVADER HPV ASR
TM56 - COMBINED HPV GENOTYPING AND CELL-BASED E6, E7 MRNA (HPV ONCOTECT) DETECTION IN CERVICAL CYTOLOGY SPECIMENS PERFORMED ON A MOLECULAR HYBRID PLATFORM (MOHP) MAXIMIZES SENSITIVITY AND POSITIVE PREDICTIVE VALUE FOR BIOPSY-PROVEN CIN 2 OR ABOVE
TM57 - HPV E6, E7 mRNA EXPRESSION IN ECTOCERVICAL CELLS (HPV ONCOTECT) PREDICTS DISEASE PROGRESSION IN WOMEN WITH LOW GRADE INTRAEPITHELIAL NEOPLASIA (LSIL)
TM58 - TGF-B1 IN SERUM AND BIOPSY OF WOMEN WITH PRE INVASIVE LESIONS OF THE UTERINE CERVIX INFECTED OR NOT WITH PAPILLOMAVIRUSES HUMAN
TM59 - IL-2, IL-10 AND IL-2R DETERMINATION IN PATIENT BIOPSY AND SERUM WITH UTERINE CERVIX PREINVASIS LESIONS HUMAN PAPILLOMAVIRUS INFECTION
TM60 - HUMAN PAPILLOMAVIRUS (HPV) AND CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN ATTENDING IN DIFERENTS PUBLIC HEALTH CENTERS FROM MARACAIBO, VENEZUELA
TM61 - EVALUATION OF THE FLOCKED SWAB +UTM FOR COLLECTION OF CERVICAL SPECIMENS FOR MOLECULAR DETECTION OF HUMAN PAPILLOMA VIRUS

Session IV
TE1 - DENGUE ENCEPHALOPATHY IN NORTHERN INDIAN CHILDREN: CLINICAL MANIFESTATIONS AND COMPARISON WITH NON DENGUE
TE2 - INACTIVATION OF CHIKUNGUNYA VIRUS WITH A LYSIS REAGENT CONTAINING GUANIDINE THIOCYANATE AND TRITON X-100
TE3 - Abstract Withdrawn
TE4 - PERSISTENCE OF ANTIBODIES TO WEST NILE VIRUS NONSTRUCTURAL PROTEIN 5 AS ASSESSED USING FOLLOW-UP PLASMA SPECIMENS FROM VIREMIC BLOOD DONORS
TE5 - DEMONSTRATION OF THE VALUE OF DETERMINING AVIDITY OF WEST NILE VIRUS IGG ANTIBODIES IN A REFERENCE LABORATORY SETTING
TE6 - THE APPLICATION OF A HIGH THROUGHPUT MICROSPHERE IMMUNOASSAY PLATFORM FOR ARBOVIRUS DIAGNOSTICS
TE7 - SCREENING OF SERUM AND CEREBROSPINAL FLUID FOR WEST NILE VIRUS
TE8 - WEST NILE VIRUS RNA PROFICIENCY TESTING BY CANADIAN LABORATORIES
TE9 - APPLICATION OF BACTERIOPHAGE MS2 AS AN INTERNAL EXTRACTION CONTROL FOR NUCLEIC ACID AMPLIFICATION TESTS
TE10 - VALIDATION OF SUPER E-MIX SHELL VIAL CULTURE AND THE D3 ENTEROVIRUS IFA KIT FOR IDENTIFICATION OF ENTEROVIRUS
TE11 - COMPARISON OF DHIS D3 ENTEROVIRUS REAGENT TO THE IMAGEN ENTEROVIRUS REAGENT FOR THE CONFIRMATION OF ENTEROVIRUS USING sE-MIX (A549/sBGMK) CELL LINE IN MULTI-WELL PLATES
TE12 - COMPARISON OF DIAGNOSTIC HYBRIDS, INC. D3 IFA ENTEROVIRUS IDENTIFICATION KIT TO MILLIPORE LIGHT DIAGNOSITICS PAN-ENTEROVIRUS REAGENT
TE13 - RECOGNITION AND MANAGEMENT OF GENEXPERT ENTEROVIRUS INVALID RESULTS FOR DETECTION OF ENTEROVIRUSES IN CEREBROSPINAL FLUID
TE14 - EVALUATION OF PREVIOUSLY EXTRACTED VIRAL RNA WITH THE GeneXpert® ENTEROVIRUS ASSAY FOR USE WITH SAMPLES OF LIMITED QUANTITY
TE15 - DETECTION OF ENTEROVIRUSES IN NON-CEREBROSPINAL FLUID SPECIMENS FROM PEDIATRIC PATIENTS BY CEPHEID XPERT EVTM PCR
TE16 - SIMULTANEOUS DETECTION AND DIFFERENTIATION OF HERPES SIMPLEX VIRUSES AND ENTEROVIRUSES IN CEREBROSPINAL FLUID BY EQ-PCR
TE17 - MULTI-CENTER EVALUATION OF A REAL TIME NASBA TEST FOR DETECTION OF ENTEROVIRUS IN CEREBROSPINAL FLUID FROM PEDIATRIC PATIENTS
TE18 - IMPACT OF MOLECULAR DIAGNOSTIC IN ASEPTIC MENINGITIS
TE19 - ASEPTIC MENINGITIS: PREVALENCE OF ENTEROVIRUS (EV)
TE20 - EVOLUTION OF THE NEW YORK STATE VIRAL ENCEPHALITIS MOLECULAR DETECTION PROGRAM
TE21 - SEVERE NEONATAL DISEASE ASSOCIATED WITH COXSACKIEVIRUS B1, UNITED STATES, 2007
TE22 - EFFICACY OF PHAGE T4 AS INTERNAL CONTROLS FOR PCR AMPLIFICATION IN CSF SPECIMENS
TE23 - ENCEPHALITIS CYTOKINE PROFILES AND DIFFERENTIATION OF UNDERLYING ETIOLOGY
TE24 - MOLECULAR EPIDEMIOLOGY AND GENOTYPING ANALYSIS ON SAPOVIRUS ASSOCIATED ACUTE GASTROENTERITIS OUTBREAKS IN ALBERTA, CANADA DURING 2004 - 2007
TE25 - ROTAVIRUS PREVALENCE AMONG NEONATES AND OLDER INFANTS IN MARACAIBO, VENEZUELA
TE26 - DEVELOPMENT OF A MULTIPLEX PCR FOR THE DETECTION OF NOROVIRUS, ROTAVIRUS AND ADENOVIRUS THAT USES THE LUMINEX xMAP SYSTEM
TE27 - VALIDATION OF A TaqMan REAL TIME RT-PCR FOR THE DETECTION OF NOROVIRUSES (NV) AND SUBTYPING GENOGROUPS I AND II (GI, GII)
TE28 - DEVELOPMENT OF A MULTICODE-RTx® PCR ASSAY FOR DETECTION OF NOROVIRUSES
TE29 - REAL-TIME REVERSE TRANSCRIPTASE PCR FOR DETECTION OF NOROVIRUS IN INFANTS AND YOUNG CHILDREN
TE30 - AUTOMATED NOROVIRUS DETECTION: REDUCING THE RISKS FOR INFECTION IN ROUTINE DIAGNOSTIC LABORATORIES
TE31 - EMERGENCE OF A PREDOMINATING VARIANT OF NOROVIRUS IN CALIFORNIA DURING the 2006-2007 SEASON
TE32 - USE OF M4RT TRANSPORT MEDIUM FOR THE DETECTION OF TRICHOMONAS VAGNALIS, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE IN THE GEN-PROBE APTIMA® TV ASR (ATV) AND APTIMA® COMBO 2 (AC2) ASSAYS
TE33 - COMPARISON OF THE APTIMA (GEN-PROBE) ASSAY (CT/GC) ON ENDOCERVICAL SPECIMENS TO SUREPATH LIQUID PAPS FACILITATED BY A REAL TIME DATABASE
TE34 - COMPARISON OF THE BECTON DICKINSON PROBETEC AND VIPER SYSTEMS FOR THE DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE
TE35 - PERFORMANCE OF THE BD PROBETEC CTQX AND GCQX AMPLIFIED DNA ASSAYS* WITH PRESERVCYT® SPECIMENS ON THE BD VIPER SYSTEM IN EXTRACTED MODE*
TE36 - PERFORMANCE OF THE BD PROBETECTM CTQX AND GCQX AMPLIFIED DNA ASSAYS* WITH BD SUREPATHTM PRESERVATIVE FLUID
TE37 - EVALUATION OF THE BD VIPERTM SYSTEM IN EXTRACTED MODE TO DETECT CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE IN BD SUREPATHTM AND PRESERVCYT® CYTOLOGY SPECIMENS
TE38 - EVALUATION OF THE BD VIPERTM SYSTEM IN EXTRACTED MODE* TO DETECT CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE IN MALE SWAB AND URINE SPECIMENS
TE39 - PERFORMANCE OF THE BD VIPER SYSTEM IN EXTRACTED MODE* WITH THE NEW BD PROBETEC CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE Qx AMPLIFIED DNA ASSAYS*
TE40 - EVALUATION OF THE ABBOTT M2000sp/rt CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE REAL-TIME PCR ASSAYS AND COMPARISON WITH THE ROCHE COBAS AMPLICOR CT/NG PCR TESTS
TE41 - RELIABILITY OF THE BD VIPER SYSTEM IN EXTRACTED MODE* FOR THE DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE
TE42 - DETECTION OF CHLAMYDIA TRACHOMATIS IN SUREPATH LIQUID-BASED PAP SAMPLES BY THE APTIMA COMBO 2 ASSAY - SAMPLES TRANSFERRED 3 VERSUS 6 DAYS AFTER SPECIMEN COLLECTION
TE43 - USE OF THE INTERNET TO USED TO SCREEN WOMEN FOR CHLAMYDIA TRACHOMATIS: ACCEPTIBILITY, PREVALENCE, AND RISK FACTORS
TE44 - EVALUATION OF EXPANDED USE OF COPANs UTM AND ESWAB TRANSPORT MEDIA FOR MAINTAINING VIABILITY OF TRICHOMONAS VAGINALIS IN TRANSPORT
TE45 - DEVELOPMENT OF THE QIASYMPHONY® SYSTEM: FULLY AUTOMATED PURIFICATION OF VIRAL AND BACTERIAL NUCLEIC ACIDS FROM A VARIETY OF SPECIMENS
TE46 - CULTURE VERSUS PCR FOR THE ETIOLOGIC DIAGNOSIS OF COMMUNITY-ACQUIRED PNEUMONIA IN ANTIBIOTIC PRETREATED PEDIATRIC PATIENTS
TE47 - EVALUATION OF THE SimplexaTM ATYPICAL PNEUMONIA REAL-TIME PCR ASSAY WITH DIFFERENT EXTRACTION METHODS AND DETECTION INSTRUMENTS
TE48 - TESTING THE NEW QIAGEN® EZ1® ADVANCED* FOR VIRAL APPLICATIONS AND PATHOGEN DECONTAMINATION
TE49 - DEVELOPMENT OF A STABLE AND VERSATILE CONTROL FOR MRSA DETECTION
TE50 - PARALLEL CHLAMYDIA CULTURE OF RECTAL SAMPLES WITH URINE/CERVICAL SAMPLES TESTED BY ROCHE AMPLICOR ASSAY
TE51 - COMPARISON OF SYPHILIS (T. PALLIDUM) SCREENING TESTING WITH A NON-TREPONEMAL TEST (VDRL) AND A TREPONEMAL TEST ELISA (TREPSURE)
TE52 - COMPARISON OF IgM CMV ASSAYS ON BRONX PATIENTS: A CAUSE FOR CONCERN
TE53 - LOOKING FOR A 96 WELL EXTRACTION INSTRUMENT; AN EVALUATION OF THE BECKMAN VIDIERA AND ABBOTT M2000 FOR VIRAL DNA AND RNA
TE54 - RAPID DETECTION OF ANIMAL PATHOGENS AND POTENTIAL ZOONOSES BY BEAD-BASED MULTIPLEXED RT-PCR
TE55 - A COMPARISON OF FOUR AUTOMATED DEVICES TO MANUAL SPIN COLUMNS FOR VIRAL DNA PURIFICATION
TE56 - PERFORMANCE OF THE QIAGEN QIACUBE® AND ROCHE MAGNA PURE COMPACT® FOR THE EXTRACTION OF VIRAL NUCLEIC ACID
TE57 - MODIFIED RNA TECHNOLOGY (MRT): APPLICATION OF THE MRT METHOD TO STABILIZE VIRAL LOAD IN PRIMARY SAMPLES, IN COMBINATION WITH APPROVED DETECTION ASSAYS
TE58 - MODIFIED RNA TECHNOLOGY (MRT): A NOVEL STABILIZATION AND EXTRACTION METHOD FOR VIRAL NUCLEIC ACIDS, LEADING TO HIGH SENSITIVITY IN DETECTION ASSAYS
TE59 - MODIFIED RNA TECHNOLOGY (MRT): A NOVEL METHOD TO STABILIZE NUCLEIC ACIDS IN PRIMARY SAMPLES FOR VIRAL DIAGNOSTICS AND TO INACTIVATE HUMAN PATHOGENS
TE60 - PERFORMANCE STUDY OF THE HANDYLAB JAGUAR PLATFORM
TE61 - EVALUATION OF AUTOMATED EXTRACTION OF VIRAL RNA USING THE HANDYLAB JAGUAR PLATFORM
TE62 - A NOVEL NUCLEIC ACID SIMPLIFICATION PROCEDURE CAPABLE OF THE DETECTION MULTIPLE STRAINS OF BOTH DNA AND RNA VIRUSES IN A SINGLE REACTION
TE63 - A COMMERCIALLY AVAILABLE ENHANCED RHABDOMYOSARCOMA CELL LINE (MGRD) FOR THE DETECTION OF ACETYLCHOLINE RECEPTOR (AChR) MODULATING ANTIBODY IN PATIENTs WITH SUSPECTED MYASTHENIA GRAVIS
TE64 - SURVEY SAYS: CONFIRM THOSE RAPIDS
TE65 - THREE-YEAR ASSESSMENT OF A FULLY AUTOMATED, MULTIPLEXED, ONE-STEP, REAL TIME RT-PCR ASSAY IN PUERTO RICO?S SURVEILLANCE SYSTEM